Figure 2
Percentage of patients with adverse events of patients (AEs) self-reported in in total population, control, tapentadol (TAP) and oxycodone/naloxone (OXN) cases groups.
Figure 2 | Scientific Reports
Percentage of patients with adverse events of patients (AEs) self-reported in in total population, control, tapentadol (TAP) and oxycodone/naloxone (OXN) cases groups.
